Home
Storia in 1 fonti
Lilly buys non-opioid pain drugmaker 4E
It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
Raccontata da
biopharmadive.com
It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
